Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

New compounds may soon be tested to treat excessive hair growth in women.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Current research explores hair growth drugs, while future research aims for personalized treatments.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Preventing hair loss is more effective than regrowth; oral finasteride is a realistic option.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Most types of hair loss can regrow naturally, but there are no effective cures for male pattern or age-related hair loss, and only limited options for females.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Iron deficiency is linked to female pattern hair loss.